EFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIALEFFICACY OF FILGOTINIB IN PATIENTS WITH ULCERATIVE COLITIS BY LINE OF THERAPY IN THE PHASE 2B/3 SELECTION TRIAL

Laurent Peyrin-Biroulet  1     Iris Dotan  2     Alessandra Oortwijn  3     Brian Feagan  4     Toshifumi Hibi  5     Virginia Taliadouros  3     Sally Zhao  6     Jie Zhang  7     Jeremy Hsieh    
1 Nancy University Hospital,Nancy,France
2 Rabin Medical Centre,Petah Tikva,Israel
3 Galapagos NV,Leiden,Netherlands
4 Alimentiv Inc.,London, Ontario,Canada
5 Kitasato Institute Hospital, Kitasato University,Tokyo,Japan
6 Gilead Sciences, Inc.,Foster City,United States
7 Gilead Sciences, Inc.,Foster City,Uni

Citation
United European Gastroenterology Journal 2021; 9 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing